119 related articles for article (PubMed ID: 2417634)
1. Cerebrospinal fluid monoamine precursor and metabolite levels in children treated for leukemia: age and sex effects and individual variability.
Riddle MA; Anderson GM; McIntosh S; Harcherik DF; Shaywitz BA; Cohen DJ
Biol Psychiatry; 1986 Jan; 21(1):69-83. PubMed ID: 2417634
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cerebrospinal fluid monoamine metabolites in peripubertal chimpanzees (Pan troglodytes).
Fontenot MB; Musso MW; Watson SL; Anderson GM
J Med Primatol; 2010 Feb; 39(1):24-31. PubMed ID: 19843204
[TBL] [Abstract][Full Text] [Related]
3. Neuroamine related compounds in the CSF of hydrocephalic rabbits.
Olmstead CE; Lazareff JA; Orlino EN; Fluharty AL; Faull KF; Peacock WJ; Wehby-Grant MC; Gayek RJ; Fisher RS
Neuroreport; 1995 Sep; 6(13):1769-72. PubMed ID: 8541478
[TBL] [Abstract][Full Text] [Related]
4. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid (CSF) and brain monoamine metabolites in the developing rat pup.
Shaywitz BA; Anderson GM; Cohen DJ
Brain Res; 1985 Jan; 349(1-2):225-32. PubMed ID: 2580600
[TBL] [Abstract][Full Text] [Related]
6. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
Eklundh T; Eriksson M; Sjöberg S; Nordin C
J Psychiatr Res; 1996; 30(3):201-8. PubMed ID: 8884658
[TBL] [Abstract][Full Text] [Related]
7. Gradients of concentrations of tryptophan and 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF).
Sourkes TL; Young SN; Garelis E; Lal S
Acta Vitaminol Enzymol; 1975; 29(1-6):97-9. PubMed ID: 1244132
[TBL] [Abstract][Full Text] [Related]
8. Individual differences in basal cisternal cerebrospinal fluid 5-HIAA and HVA in monkeys. The effects of gender, age, physical characteristics, and matrilineal influences.
Raleigh MJ; Brammer GL; McGuire MT; Pollack DB; Yuwiler A
Neuropsychopharmacology; 1992 Dec; 7(4):295-304. PubMed ID: 1282317
[TBL] [Abstract][Full Text] [Related]
9. Central neurochemical ultradian variability in depression.
Salomon RM; Johnson BW; Schmidt DE
Dis Markers; 2006; 22(1-2):65-72. PubMed ID: 16410652
[TBL] [Abstract][Full Text] [Related]
10. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
von Holst H; Lindquist C; Sedvall G
Acta Neurochir (Wien); 1985; 77(3-4):146-51. PubMed ID: 2416192
[TBL] [Abstract][Full Text] [Related]
11. Serotonin metabolites in the cerebrospinal fluid in sudden infant death syndrome.
Rognum IJ; Tran H; Haas EA; Hyland K; Paterson DS; Haynes RL; Broadbelt KG; Harty BJ; Mena O; Krous HF; Kinney HC
J Neuropathol Exp Neurol; 2014 Feb; 73(2):115-22. PubMed ID: 24423636
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population.
Hyland K; Surtees RA; Heales SJ; Bowron A; Howells DW; Smith I
Pediatr Res; 1993 Jul; 34(1):10-4. PubMed ID: 7689195
[TBL] [Abstract][Full Text] [Related]
13. Neurophysiological measures related to levels of 5-hydroxyindoleacetic acid, homovanillic acid and tryptophan in cerebrospinal fluid of psychiatric patients.
Gottfries CG; von Knorring L; Perris C
Neuropsychobiology; 1976; 2(1):1-8. PubMed ID: 1004696
[TBL] [Abstract][Full Text] [Related]
14. Developmental changes in cerebrospinal fluid concentrations of monoamine-related substances in patients with dentatorubral-pallidoluysian atrophy.
Takeuchi Y; Matsushita H; Sakai H; Kawano H; Ochi M
J Child Neurol; 2001 Feb; 16(2):79-82. PubMed ID: 11292229
[TBL] [Abstract][Full Text] [Related]
15. Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects.
Hagenfeldt L; Bjerkenstedt L; Edman G; Sedvall G; Wiesel FA
J Neurochem; 1984 Mar; 42(3):833-7. PubMed ID: 6198473
[TBL] [Abstract][Full Text] [Related]
16. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
Hsiao JK; Colison J; Bartko JJ; Doran AR; Konicki PE; Potter WZ; Pickar D
Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid monoamine metabolites in patients with infantile spasms.
Silverstein F; Johnston MV
Neurology; 1984 Jan; 34(1):102-5. PubMed ID: 6197678
[TBL] [Abstract][Full Text] [Related]
18. Motor activity increases tryptophan, 5-hydroxyindoleacetic acid, and homovanillic acid in ventricular cerebrospinal fluid of the conscious rat.
Chaouloff F; Laude D; Guezennec Y; Elghozi JL
J Neurochem; 1986 Apr; 46(4):1313-6. PubMed ID: 2419509
[TBL] [Abstract][Full Text] [Related]
19. [The effect of amino acids on neurotransmitter metabolites in the cerebrospinal fluid].
Zeman J; Böswart J
Cas Lek Cesk; 1991 May; 130(14):425-7. PubMed ID: 1712669
[TBL] [Abstract][Full Text] [Related]
20. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
